GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » Debt-to-Revenue

Neutra (Neutra) Debt-to-Revenue : 13.50 (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Neutra's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was $0.00 Mil. Neutra's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Oct. 2023 was $0.05 Mil. Neutra's annualized Revenue for the quarter that ended in Oct. 2023 was $0.00 Mil. Neutra's annualized Debt-to-Revenue for the quarter that ended in Oct. 2023 was 13.50.


Neutra Debt-to-Revenue Historical Data

The historical data trend for Neutra's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra Debt-to-Revenue Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 52.00 24.00 2.61 0.79

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.20 2.25 2.25 3.38 13.50

Competitive Comparison of Neutra's Debt-to-Revenue

For the Biotechnology subindustry, Neutra's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neutra's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neutra's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Neutra's Debt-to-Revenue falls into.



Neutra Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Neutra's Debt-to-Revenue for the fiscal year that ended in Jan. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0.054) / 0.068
=0.79

Neutra's annualized Debt-to-Revenue for the quarter that ended in Oct. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0.054) / 0.004
=13.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Oct. 2023) Revenue data.


Neutra Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Neutra's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243